Freshpet, Inc. reported a 15.5% increase in net sales to $305.6 million for Q2 2026, driven by volume gains despite slight price/mix pressure. The company improved its adjusted gross margin to 48.6% and raised its 2026 net sales growth guidance to 10-12%, along with an adjusted EBITDA outlook of $210-$220 million. Freshpet also updated its long-term adjusted gross margin target to above 49%, reflecting confidence in its manufacturing scale and omnichannel strategy. The company generated strong cash flow and net income of $19.5 million for the quarter, signaling resilience amid economic challenges and competition.
Avalanche (AVAX) has surged past the $10 mark after breaking out from a consolidation range between $7.00 and $8.20, supported by a sharp increase in trading volume. The price climbed to around $10.27, clearing multiple resistance levels and reclaimi...
Zcash (ZEC) price retreated from a recent high near $1,600 to around $1,443 amid increased selling pressure, signaling a healthy correction after a strong rally. Despite the pullback, technical indicators remain bullish, with ZEC holding above major ...
Avalanche's AVAX price rose 18% due to three key events: New York Life Investment Management launched its first tokenized high-yield bond fund on Avalanche, Paxos added AVAX to its regulated payment services, and a network upgrade on September 22 wil...
Orthocell Ltd has made its first commercial sales of Remplir, a nerve repair product, in Thailand following Thai FDA approval and the appointment of MediTime as its exclusive distributor. This launch opens access to Thailand's estimated $84 million n...
Strategy (MSTR) stock surged 16.39%, closing at $153.92 after heavy trading volume more than doubling its average daily shares. The rise is closely tied to Bitcoin's price, as Strategy holds around 845,000 BTC worth about $69 billion, making Bitcoin'...
